Germany
Japan
United Kingdom
China
USD 428.00
In Stock
Antibodies
View as table Download
USD 428.00
In Stock
Rabbit Polyclonal LSD1 Antibody
| Applications | ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-LSD1 antibody: human LSD1 (Lysine-specific demethylase 1), using a KLH-conjugated synthetic peptide from the inner part of the protein. |
Rabbit Polyclonal RARA Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-RARA antibody: human RARA (Retinoic Acid Receptor alpha) using two KLH-conjugated synthetic peptides containing sequences from the C-terminal region of the protein. |
c-Myc (MYC) mouse monoclonal antibody, clone 9E10, HRP
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | HRP |
Rabbit Polyclonal ASH2 Antibody
| Applications | ELISA, IF, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-ASH2 antibody: mouse Ash2 (absent, small, or homeotic 2), using 3 different KLH-conjugated synthetic peptides, 2 containing an amino acid sequence from the central and 1 containing an amino acid sequence from the C-terminal part of |
Rabbit Polyclonal LSD1 Antibody
| Applications | ELISA, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-LSD1 antibody: human JMJD2a (Jumonji domain containing 2a), using a KLH-conjugated synthetic peptide containing a sequence from the central part of the protein. |
Rabbit Polyclonal MBD1 Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-MBD1 antibody: human MBD1 (Methyl-CpG-binding domain protein 1), using a KLH-conjugated synthetic peptide containing a sequence from the N-terminal part of the protein. |
Rabbit Polyclonal PPARG Antibody
| Applications | ELISA, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-PPARG antibody: human PPARG (peroxisome proliferator-activated receptor gamma), using a KLH-conjugated synthetic peptide containing a sequence from the central part of the protein. |
c-Myc (MYC) mouse monoclonal antibody, clone 9E10, AP
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | AP |
Rabbit Polyclonal CBFb Antibody
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-CBFb antibody: human CBFb (core-binding factor, beta subunit) using two KLH-conjugated synthetic peptides containing sequences from the central region of the protein. |
Rabbit Polyclonal ETO Antibody
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-ETO antibody: human ETO (runt-related transcription factor 1; translocated to, 1 (cyclin D-related)) using two KLH-conjugated synthetic peptides containing sequences from the N-terminal and the central region of the protein, respect |
Rabbit Polyclonal Jarid1c Antibody
| Applications | ELISA, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-Jarid1c antibody: mouse Jarid1c (jumonji, AT rich interactive domain 1C), using 3 KLH-conjugated synthetic peptides containing sequences from the inner part of the protein. |
Rabbit Polyclonal SOX4 Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-SOX4 antibody: human SOX4 (SRY (sex determining region Y)-box 4), using two KLH-conjugated synthetic peptides containing a sequence from the N-terminus and from the C-terminus of the protein, respectively. |
Rabbit Polyclonal DNMT1 Antibody
| Applications | ELISA, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-DNMT1 antibody: mouse DNMT1 (DNA (cytosine-5)-methyltransferase 1), using a KLH-conjugated synthetic peptide containing an amino acid sequence from the C-terminal part of the protein. |
Rabbit Polyclonal Hira Antibody
| Applications | ELISA, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-Hira antibody: mouse Hira (histone cell cycle regulation defective homolog A), using a KLH-conjugated synthetic peptide containing an amino acid sequence from the central part of the protein |
Rabbit Polyclonal JMJD2a Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-JMJD2a antibody: human JMJD2a (Jumonji domain containing 2a), using a KLH-conjugated synthetic peptide containing a sequence from the central part of the protein. |
Rabbit Polyclonal Jarid1b Antibody
| Applications | ELISA, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-Jarid1b antibody: mouse Jarid1b (Jumonji, AT rich interactive domain 1B), using a KLH-conjugated synthetic peptides containing an amino acid sequence from the central part of the protein. |
Rabbit Polyclonal MBD2 Antibody
| Applications | ELISA, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-MBD2 antibody: mouse MBD2 (methyl-CpG binding domain protein 2), using a KLH-conjugated synthetic peptide containing an amino acid sequence from the central part of the protein |
Rabbit Polyclonal PAPOLA Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-PAPOLA antibody: human PAPOLA (polyA polymerase alpha), using a KLH-conjugated synthetic peptide containing a sequence from the C-terminal part of the protein. |
Rabbit Polyclonal AML-ETO Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-AML-ETO antibody: the AML-ETO (RUNX1) fusion protein, using 3 different KLH-conjugated synthetic peptides. The antibody recognizes the ETO (RUNX1T1) part of the fusion protein. |
Rabbit Polyclonal SPI1 Antibody
| Applications | ELISA, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-SPI1 antibody: mouse SPI1 (spleen focus forming virus (SFFV) proviral integration oncogene), using two KLH-conjugated synthetic peptides containing a sequence from the N-terminus and from the C-terminus of the protein, respectively. |
Rabbit Polyclonal ZMYND8 Antibody
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-ZMYND8 antibody: human ZMYND8 (zinc finger, MYND-type containing 8), using a KLH-conjugated synthetic peptide containing a sequence from the C-terminal part of the protein. |
TGF beta 1 (TGFB1) mouse monoclonal antibody, clone 8C4, Azide Free
| Applications | ELISA, FN, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
c-Myc (MYC) chicken polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human |
| Immunogen | Synthetic peptide containing the Human c-myc epitope (i.e., EQKLISEEDL) conjugated to KLH. The first injection included complete Freund's adjuvant; subsequent injections included incomplete Freund's adjuvant. Eggs were collected after the fourth injection, and antibodies were purified from the yolks using a proprietary method that yields a purity of >90%. |
c-Myc (MYC) mouse monoclonal antibody, clone 9E10, Purified
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
Rabbit Polyclonal KEAP1 Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | DNA immunization. This antibody is specific for the N Terminus Region of the target protein. |
Active filters
Applications
- ELISA
Families
- Transcription Factors
Filter by
Category
Target Symbol
- CD80 (20)
- TP63 (14)
- MYC (13)
- TLE1 (12)
- TNF (12)
- ERG (10)
- HES1 (8)
- FOXO3 (7)
- JUN (7)
- SOX17 (7)
- STAT4 (7)
- HDAC10 (6)
- MEF2C (6)
- NEUROG1 (6)
- BRCA1 (5)
- CREB1 (5)
- HDAC1 (5)
- STAT1 (5)
- STAT5B (5)
- CDK11B (4)
- CTNNB1 (4)
- ID3 (4)
- MDM2 (4)
- PAX5 (4)
- POGK (4)
- RARA (4)
- SMAD6 (4)
- STAT5A (4)
- TNFRSF1A (4)
- TP53 (4)
- BCL3 (3)
- CALR (3)
- CCNH (3)
- CREG1 (3)
- CUX1 (3)
- DLX2 (3)
- ELK1 (3)
- EP300 (3)
- GAS7 (3)
- MEF2A (3)
- MYB (3)
- NRG1 (3)
- RUNX1 (3)
- RUNX1T1 (3)
- RUNX2 (3)
- SMAD3 (3)
- SOX5 (3)
- TARDBP (3)
- TRIM28 (3)
- YY1 (3)
- AHR (2)
- APEX1 (2)
- ARNT (2)
- ATF2 (2)
- ATF6 (2)
- BCL11A (2)
- CIAO1 (2)
- CNBP (2)
- CRABP2 (2)
- ESR1 (2)
- EZH2 (2)
- FOXA1 (2)
- FOXO4 (2)
- FUBP1 (2)
- HDAC3 (2)
- HMGA1 (2)
- HMGB1 (2)
- HMGB2 (2)
- ING2 (2)
- IRAK1 (2)
- KAT2A (2)
- KDM1A (2)
- KDM4A (2)
- KLF7 (2)
- LHX1 (2)
- LITAF (2)
- MAFK (2)
- MBD2 (2)
- MECOM (2)
- MSX1 (2)
- NFATC1 (2)
- PAX7 (2)
- PBX3 (2)
- PIAS2 (2)
- PPARG (2)
- SIRT2 (2)
- SOX9 (2)
- TGFB1 (2)
- TP73 (2)
- WT1 (2)
- XRCC6 (2)
- ZEB2 (2)
- ACAD8 (1)
- AIP (1)
- ARID3A (1)
- ASH2L (1)
- ATF1 (1)
- ATF4 (1)
- ATF5 (1)
- BTG1 (1)
Reactivities
Antibody Hosts
Isotypes
Clonalities
Conjugates
Assay Types
Assay Platforms
Pathways
- Pathways in cancer (96)
- MAPK signaling pathway (65)
- Chronic myeloid leukemia (52)
- Toll-like receptor signaling pathway (50)
- Wnt signaling pathway (48)
- TGF-beta signaling pathway (47)
- Cell cycle (45)
- Jak-STAT signaling pathway (42)
- Acute myeloid leukemia (38)
- Colorectal cancer (36)
- ErbB signaling pathway (36)
- Systemic lupus erythematosus (33)
- Allograft rejection (32)
- Graft-versus-host disease (32)
- Type I diabetes mellitus (32)
- Endometrial cancer (31)
- Neurotrophin signaling pathway (27)
- Prostate cancer (27)
- T cell receptor signaling pathway (26)
- Small cell lung cancer (25)
- Apoptosis (24)
- Bladder cancer (24)
- Thyroid cancer (24)
- Huntington's disease (23)
- Amyotrophic lateral sclerosis (ALS) (21)
- Chemokine signaling pathway (21)
- Notch signaling pathway (21)
- Pancreatic cancer (21)
- Adipocytokine signaling pathway (20)
- Autoimmune thyroid disease (20)
- Cell adhesion molecules (CAMs) (20)
- Viral myocarditis (20)
- Alzheimer's disease (18)
- Cytokine-cytokine receptor interaction (18)
- Ubiquitin mediated proteolysis (16)
- Focal adhesion (15)
- Natural killer cell mediated cytotoxicity (15)
- Renal cell carcinoma (15)
- B cell receptor signaling pathway (14)
- Dilated cardiomyopathy (14)
- Hypertrophic cardiomyopathy (HCM) (14)
- NOD-like receptor signaling pathway (14)
- RIG-I-like receptor signaling pathway (14)
- Fc epsilon RI signaling pathway (13)
- Melanogenesis (13)
- Non-small cell lung cancer (13)
- Adherens junction (12)
- Asthma (12)
- GnRH signaling pathway (12)
- Hematopoietic cell lineage (12)
- Maturity onset diabetes of the young (12)
- Type II diabetes mellitus (12)
- Melanoma (11)
- Glioma (10)
- p53 signaling pathway (10)
- Epithelial cell signaling in Helicobacter pylori infection (9)
- Antigen processing and presentation (8)
- Basal cell carcinoma (8)
- Base excision repair (5)
- Endocytosis (5)
- Insulin signaling pathway (5)
- Leukocyte transendothelial migration (5)
- Metabolic pathways (5)
- Nucleotide excision repair (5)
- Tight junction (5)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (4)
- Long-term potentiation (4)
- PPAR signaling pathway (4)
- Pathogenic Escherichia coli infection (4)
- Axon guidance (3)
- Prion diseases (3)
- VEGF signaling pathway (3)
- Cysteine and methionine metabolism (2)
- Cytosolic DNA-sensing pathway (2)
- DNA replication (2)
- Non-homologous end-joining (2)
- RNA degradation (2)
- Biosynthesis of unsaturated fatty acids (1)
- Circadian rhythm - mammal (1)
- Fc gamma R-mediated phagocytosis (1)
- Glycolysis / Gluconeogenesis (1)
- Long-term depression (1)
- Neuroactive ligand-receptor interaction (1)
- Oocyte meiosis (1)
- Primary immunodeficiency (1)
- Regulation of actin cytoskeleton (1)
- Valine (1)
- leucine and isoleucine degradation (1)